GME
GameStop Corp.
GME's fundamentals are strong: its operating margin rose 11 points to 14% and it turned 19% of its revenue into free cash flow, though revenue fell 7.7%. At 17x earnings, it's trading less than half its usual 44x. Analysts expect earnings to fall sharply.
TOUR
Tuniu Corporation
There isn't enough reported data to score TOUR yet.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
TOUR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Healthy |
TOUR's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME's PE is in its cheap range at 17x. Analysts expect earnings to fall, which would put today's price at 38x next year's earnings, in its fair range.
TOUR PE Valuation
TOUR has no meaningful PE right now: it lost money over the past year.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
TOUR Forward outlook
There aren't enough analyst estimates for TOUR to show an outlook.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME's earnings per share have climbed steadily: $1.54 over the past year, up 93% from the year before, and higher year over year for 15 quarters in a row.
TOUR Earnings Per Share
TOUR and GME do not have enough comparable growth data to identify a winner.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
TOUR has the stronger quarterly revenue trend. Revenue is down 19% for GME versus up 13% for TOUR.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME's operating margin was 20% last quarter, up 13 points from the same quarter a year ago, near the top of its range since 2019.
TOUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $19.9M | +13% |
| Q4 2025 | $18.5M | +20% |
| Q3 2025 | $30.3M | +8.6% |
| Q2 2025 | $20.2M | +15% |
| Q1 2025 | $17.6M | +8.9% |
| Q4 2024 | $15.4M | +2.8% |
| Q3 2024 | $27.9M | +4.4% |
| Q2 2024 | $17.5M | +17% |
TOUR's revenue has grown year over year for 13 quarters in a row: $20M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -2.8% | +6.4 points |
| Q4 2025 | 0.9% | +13 points |
| Q3 2025 | 6.8% | -8.8 points |
| Q2 2025 | 5.3% | -24 points |
| Q1 2025 | -9.2% | -21 points |
| Q4 2024 | -12% | +111 points |
| Q3 2024 | 16% | -2.1 points |
| Q2 2024 | 29% | +23 points |
TOUR's operating margin was −2.8% last quarter, up 6.4 points from the same quarter a year ago.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME has the stronger cash trend. Its trailing FCF is up 2,081% versus its history, compared with TOUR at down 100%.
TOUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | -100% |
| Q2 2024 | $0 | -100% |
| Q1 2024 | $0 | -100% |
| Q4 2023 | $0 | -100% |
| Q3 2023 | $250.5K | -44% |
TOUR's free cash flow has been positive every quarter since mid-2020: $0 over the past year, against $250,463 the year before.
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has 593M diluted shares, up 8.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
TOUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.3% | -88.5K shares |
| 1 year | -5.8% | -230K shares |
TOUR has the edge over GME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
GME Net Leverage
TOUR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.8x | Net Cash |
| Q4 2025 | -3.2x | Net Cash |
| Q3 2025 | -34.6x | Net Cash |
| Q2 2025 | -14.7x | Net Cash |
| Q1 2025 | -16.8x | Net Cash |
| Q4 2024 | -5.9x | Net Cash |
| Q3 2024 | -3.8x | Net Cash |
| Q2 2024 | -6.7x | Net Cash |
TOUR has more cash than debt.
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
TOUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 12.5 | Oversold |
TOUR's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
TOUR PE vs Consumer Cyclical Sector
TOUR has no meaningful PE right now: it lost money over the past year.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME has the edge over TOUR on trend strength, trading above more of its moving averages.
TOUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.86 | 3.5% below |
| 20 week MA | $4.95 | 5.3% below |
| 50 week MA | $5.94 | 21% below |
| 100 week MA | $7.53 | 38% below |
| 200 week MA | $9.63 | 51% below |
TOUR is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over TOUR on returns for 2026, with the stronger performance.
TOUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.5 | $19.2 | -18% |
| 2021 | $19.2 | $9.78 | -49% |
| 2022 | $9.78 | $16.7 | +71% |
| 2023 | $16.7 | $6.71 | -60% |
| 2024 | $6.71 | $9.85 | +47% |
| 2025 | $9.85 | $7.25 | -26% |
| 2026 YTD | $7.25 | $4.69 | -35% |
TOUR has finished lower in four of the last six years. It's down 35% so far in 2026.